Ikeda and colleagues showed that BRK and STAP-2 are highly expressed in breast cancer cells and reported that STAP-2 is phosphorylated at tyrosine-250 by BRK, thus enhancing BRK-mediated STAT3 activation [39]. This evidence concerns the gene STAP2 and breast carcinoma.